Panel Discussion

Saturday, March 8, 2025

9:25 AM - 10:05 AM ET

Panel Moderator(s)

Mark R. Hofmeyer, MD, FACC

Attending Physician - Advanced Heart Failure Associate Professor - Georgetown University School of Medicine
MedStar Health
Washington, District of Columbia, United States

No relationships to disclose
Mandeep R. Mehra, MD, MSc, FRCP

William Harvey Chair in Cardiovascular Medicine
Brigham and Women's Hospital
Needham, Minnesota, United States

No relationships to disclose
Ileana L. Pina, MD, MPH

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

No relationships to disclose

Panel Discussant(s)

Jacob Abraham, MD

Section Head, Advanced Heart Failure
Providence heart Institute
Portland, Oregon, United States

Disclosure(s): Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Adona: Consultant (Ongoing); Ancora: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CVRx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock-privately held company (Ongoing); Edwards Lifesciences: Consultant (Ongoing)
Jennifer R. Brown, MD

Director of Heart Failure Services in Annapolis, MD
MedStar Health

No relationships to disclose
Jonathan Grinstein, MD

Advanced Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation Physician
University of Chicago
MedStar Washington Hospital Center
Bethesda, MD, United States

No relationships to disclose
RK

Rania Kaoukis, MD

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose
PL

Phillip H. Lam, MD

Advanced Heart Failure Cardiologist
MedStar Health

No relationships to disclose
KAVITA SHARMA, MD

Director of Heart Failure and Cardiac Transplantation
Johns Hopkins University School of Medicine
Ellicott City, Maryland, United States

Disclosure(s): Alleviant: Consultant (Ongoing); Amgen Inc: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bayer: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Cytokinetics: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); Novo Nordisk: Consultant (Ongoing); Rivus: Consultant (Ongoing)

Disclosure(s):

Mark R. Hofmeyer, MD, FACC: No financial relationships to disclose

Mandeep R. Mehra, MD, MSc, FRCP: Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); Cadrenal: Consultant (Ongoing); Fineheart: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); FIRE-1: Consultant (Ongoing); leviticus: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Moderna: Consultant (Ongoing); NupulseCV: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Paragonix Therapeutics, Inc.: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Ileana L. Pina, MD, MPH: BOEHRINGER INGELHEIM IT.SpA.: advisory Board (Ongoing)

Jacob Abraham, MD: Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Adona: Consultant (Ongoing); Ancora: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CVRx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock-privately held company (Ongoing); Edwards Lifesciences: Consultant (Ongoing)

Jennifer R. Brown, MD: No financial relationships to disclose

Jonathan Grinstein, MD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BrioHealth: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PAC Dynamic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), This is a startup. I am the founder (Ongoing); Restore Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Data Safety Monitoring Board (Ongoing)

Rania Kaoukis, MD: No financial relationships to disclose

Phillip H. Lam, MD: No financial relationships to disclose

KAVITA SHARMA, MD: Alleviant: Consultant (Ongoing); Amgen Inc: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bayer: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Cytokinetics: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); Novo Nordisk: Consultant (Ongoing); Rivus: Consultant (Ongoing)